Dextera Surgical Inc. (fka DXTRQ)

[snakess]

fully diluted 88 million shares outstanding after everything is converted and then i assume a reverse once FDA 510 is approved for additional applications and maybe Braun agreement which actually the need to validate on the world stage. Thualman brokerage firm targets DXTR @.80- note they are having a dog and pony show for many companies soon and all this tells me is they are intending to management an offer soon, but a reverse may be first. Regardless, i do believe there is a trade coming in consideration of all the pony show coming and maybe all the warrants have been exercised.We will not know this until the next filing. In my opinion it is a buy for a trade. This company needs capital and a reverse and dilution raise i believe will happen